CAYMAN CHEMICAL

Lasofoxifene (tartrate)-25 mg

A third-generation SERM that selectively binds to human ER&alpha (IC50 = 1.5 nM) and inhibits bone loss in ovariectomized rats used in the treatment of postmenopausal osteoporosis and ER-positive breast cancer also acts as an inverse

Description

A third-generation SERM that selectively binds to human ER&alpha (IC₅₀ = 1.5 nM) and inhibits bone loss in ovariectomized rats used in the treatment of postmenopausal osteoporosis and ER-positive breast cancer also acts as an inverse

Specifications

UPC:

51111857

Condition:

New

Weight:

1.00 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

17646-25